Stephen D Wiviott Selected Research

Clopidogrel (Plavix)

11/2022	Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
1/2020	Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor.
1/2020	Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome.
10/2018	Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial).
6/2017	Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.
7/2016	Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
4/2016	PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
1/2016	Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
1/2016	Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 Trial.
7/2015	Clinical evidence for oral antiplatelet therapy in acute coronary syndromes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen D Wiviott Research Topics

Disease

115	Myocardial Infarction 04/2024 - 11/2003
73	Acute Coronary Syndrome 03/2021 - 08/2004
59	Hemorrhage 11/2022 - 10/2004
56	Stroke (Strokes) 04/2024 - 12/2006
40	ST Elevation Myocardial Infarction 03/2021 - 11/2003
37	Heart Failure 04/2024 - 08/2004
37	Type 2 Diabetes Mellitus (MODY) 10/2023 - 10/2013
32	Thrombosis (Thrombus) 10/2020 - 06/2005
30	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 06/2005
18	Unstable Angina 01/2023 - 11/2003
17	Non-ST Elevated Myocardial Infarction 11/2017 - 02/2004
14	Coronary Artery Disease (Coronary Atherosclerosis) 11/2019 - 01/2006
13	Ischemic Stroke 01/2023 - 04/2012
12	Infections 01/2023 - 10/2005
10	Atrial Fibrillation 09/2022 - 11/2013
7	Kidney Diseases (Kidney Disease) 10/2023 - 01/2019
7	Chronic Renal Insufficiency 01/2023 - 01/2010
7	Hemorrhagic Stroke 01/2023 - 07/2009
7	Neoplasms (Cancer) 01/2023 - 01/2016
7	Ischemia 05/2016 - 06/2005
6	Diabetes Mellitus 08/2023 - 10/2008
6	Overweight 01/2019 - 01/2017
6	Weight Loss (Weight Reduction) 01/2019 - 11/2014
6	Atherosclerosis 04/2016 - 06/2011
5	Obesity 12/2023 - 12/2012
5	Inflammation (Inflammations) 01/2023 - 08/2004
5	Peripheral Arterial Disease 09/2022 - 04/2012
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2015 - 10/2005
4	Hypercholesterolemia 01/2022 - 06/2011
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 01/2019
4	Vascular Diseases (Vascular Disease) 11/2018 - 08/2006
4	Transient Ischemic Attack 04/2015 - 10/2011
3	Embolism (Embolus) 09/2022 - 11/2013
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
3	Albuminuria 01/2021 - 01/2019
2	Aortic Valve Stenosis (Aortic Stenosis) 02/2024 - 09/2020

Drug/Important Bio-Agent (IBA)

48	Clopidogrel (Plavix)FDA Link 11/2022 - 06/2005
39	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2005
33	dapagliflozinIBA 10/2023 - 01/2018
21	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 09/2004
20	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 10/2004
16	omega-Chloroacetophenone (Mace)IBA 04/2024 - 05/2011
16	Heparin (Liquaemin)FDA LinkGeneric 03/2021 - 10/2004
12	Sodium-Glucose Transport ProteinsIBA 10/2023 - 01/2019
11	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 11/2014
11	evolocumabIBA 01/2023 - 01/2017
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2004
10	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 01/2018
10	LDL CholesterolIBA 01/2023 - 12/2006
10	Simvastatin (Zocor)FDA LinkGeneric 09/2020 - 09/2004
10	Atorvastatin (Lipitor)FDA Link 01/2017 - 10/2005
10	thienopyridineIBA 05/2016 - 11/2007
9	oxidized low density lipoproteinIBA 01/2023 - 10/2005
8	SodiumIBA 04/2024 - 01/2018
8	CreatinineIBA 10/2023 - 11/2003
8	otamixabanIBA 03/2021 - 12/2012
8	LipidsIBA 06/2015 - 03/2006
8	Pravastatin (Pravachol)FDA LinkGeneric 06/2011 - 10/2005
8	Tirofiban (Aggrastat)FDA Link 09/2008 - 02/2004
7	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 03/2012
7	TicagrelorIBA 11/2020 - 01/2006
7	TroponinIBA 11/2020 - 08/2004
7	Glycoproteins (Glycoprotein)IBA 01/2018 - 08/2009
6	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 08/2004
6	edoxabanIBA 09/2022 - 11/2013
6	Eptifibatide (Integrilin)FDA Link 03/2021 - 12/2012
6	lorcaserinIBA 01/2019 - 11/2014
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2017 - 12/2010
5	Troleandomycin (TAO)FDA Link 03/2021 - 09/2013
5	CholesterolIBA 11/2020 - 08/2006
5	Ezetimibe (Zetia)FDA Link 09/2020 - 06/2015
5	AnticoagulantsIBA 09/2013 - 06/2007
5	Enoxaparin (Lovenox)FDA LinkGeneric 07/2009 - 10/2004
4	pro-brain natriuretic peptide (1-76)IBA 12/2023 - 08/2013
4	AlbuminsIBA 10/2023 - 01/2019
4	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 09/2020 - 01/2017
4	Factor Xa (Coagulation Factor Xa)IBA 11/2019 - 01/2012
4	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2018
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 07/2009
4	RivaroxabanIBA 01/2018 - 01/2012
4	Cytochrome P-450 CYP2C19IBA 01/2016 - 01/2009
3	SymportersIBA 04/2024 - 01/2021
3	Natriuretic PeptidesIBA 12/2023 - 08/2004
3	saxagliptin FDA Link 11/2021 - 10/2013
3	bivalirudin (Angiomax)FDA Link 01/2018 - 06/2010
3	Streptokinase FDA Link 05/2016 - 07/2009
3	MB Form Creatine KinaseIBA 10/2015 - 02/2007
3	vorapaxarIBA 12/2014 - 04/2012
3	E 5555IBA 07/2012 - 05/2011
3	C-Reactive ProteinIBA 06/2011 - 07/2006
2	vupanorsenIBA 12/2023 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 10/2023 - 04/2011
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2023 - 01/2020

Therapy/Procedure

72	Therapeutics 04/2024 - 02/2004
32	Percutaneous Coronary Intervention 03/2021 - 11/2003
28	Stents 10/2020 - 01/2006
12	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 10/2006
3	Surgical Amputation (Amputations) 01/2022 - 01/2020
3	Secondary Prevention 01/2021 - 12/2014
3	Drug-Eluting Stents 12/2014 - 01/2006